L. Durst

Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy.

M. Mcgoon, R. Frantz, S. Bhatia, 2003, Mayo Clinic proceedings.

Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure

G. Thompson, M. Gomberg-Maitland, E. Ross, 2017, Chest.

Conversion From Sildenafil to Tadalafil

R. Oudiz, A. Waxman, R. Frantz, 2014, Journal of cardiovascular pharmacology and therapeutics.

The feasibility and value of assessing patient‐reported outcomes in pulmonary arterial hypertension

D. Schroeder, S. Kushwaha, R. Mccully, 2022, Pulmonary circulation.

Characterization of Prostacyclin‐associated Leg Pain in Patients with Pulmonary Arterial Hypertension

M. Mcgoon, K. Swetz, R. Frantz, 2017, Annals of the American Thoracic Society.

Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey.

Jeff A Sloan, J. Sloan, T. Shanafelt, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Physician Attitudes toward Palliative Care for Patients with Pulmonary Arterial Hypertension: Results of a Cross-Sectional Survey

J. Sloan, T. Shanafelt, P. Novotny, 2014, Pulmonary circulation.

Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.

C. Jellis, T. Kolb, R. Damico, 2023, Journal of the American College of Cardiology.